These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4129073)

  • 1. [Protein metabolism in women using Femigen Polfa as peroral contraceptives].
    Firek A; Pisarek-Miedzińska D; Wójcicka J; Korc R
    Ginekol Pol; 1973 Nov; 44(11):1303-8. PubMed ID: 4129073
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum protein -(Xh)-changes in pregnancy and use of ovulation inhibitons in women and men].
    Geserick G; Müller G
    Zentralbl Gynakol; 1970 Sep; 92(37):1195-200. PubMed ID: 4098488
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipid metabolism in women ingesting gestagens as contraceptives].
    Pisarek-Miedzińska D; Roszkowski I; Firek A
    Ginekol Pol; 1972; 43(12):1407-19. PubMed ID: 4119343
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of chlormadinone acetate and mestranol on blood glucose and plasma insulin. I. Six-month oral glucose tolerance test.
    Spellacy WN; Buhi WC; Birk SA; McCreary SA
    Fertil Steril; 1971 Apr; 22(4):217-23. PubMed ID: 4101969
    [No Abstract]   [Full Text] [Related]  

  • 5. [Femigen forte and mite preparations in contraception and gynecologival disorders].
    Sternadel Z; Pietrusiewicz W; Wasilewska B
    Ginekol Pol; 1970 Nov; 41(11):1227-36. PubMed ID: 4098877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of chlormadinone acetate and mestranol on blood glucose and plasma insulin. II. Twelfth month oral glucose tolerance test.
    Spellacy WN; Buhi WC; Birk SA; McCreary SA
    Fertil Steril; 1971 Apr; 22(4):224-8. PubMed ID: 4101970
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of chloramdinone and chlormadinone with mestranol preparations on the blood clotting system].
    Marcinkowski Z
    Ginekol Pol; 1978 Mar; 49(3):211-7. PubMed ID: 77805
    [No Abstract]   [Full Text] [Related]  

  • 8. [The serum levels of nonesterified fatty acids and free amino acids under the effect of the oral contraceptive, Ovosiston].
    Methfessel HD; Mlytz H; Liedtke MP; Löffler F; Methfessel G
    Z Arztl Fortbild (Jena); 1970 Sep; 64(17):880-2. PubMed ID: 4098228
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of the oral contraceptive preparation Femigen on the erythrocyte and resin uptake of 131-I-triiodothyronine].
    Pisarek-Miedzińska D; Czech W; Firek A
    Ginekol Pol; 1972 May; 43(5):595-600. PubMed ID: 4113023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effect of oral contraceptives, pregnancy and sex on iron metabolism.
    Mardell M; Symmons C; Zilva JF
    J Clin Endocrinol Metab; 1969 Nov; 29(11):1489-95. PubMed ID: 4186910
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum vitamin B 12 binding capacity and oral contraceptive hormones.
    Bianchine JR; Bonnlander B; Macaraeg PV; Hersey R; Bianchine JW; McIntyre PA
    J Clin Endocrinol Metab; 1969 Nov; 29(11):1425-8. PubMed ID: 4186909
    [No Abstract]   [Full Text] [Related]  

  • 12. Endometrial morphology after sequential medication with mestranol and chlormadinone.
    Ober WB; Decker A; Clyman MJ; Roland M
    Obstet Gynecol; 1966 Aug; 28(2):247-53. PubMed ID: 4161461
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of Gestranol used as a contraceptive on the level of some aminotransferases].
    Giermańska T; Jabloński K; Filc-Bauer A
    Pol Tyg Lek; 1972 Nov; 27(47):1839-40. PubMed ID: 4118898
    [No Abstract]   [Full Text] [Related]  

  • 14. Sequential administration of hormones for control of conception.
    Dougherty CM
    J La State Med Soc; 1966 Sep; 118(9):382-4. PubMed ID: 4166934
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urinary level of metabolites of steroid hormones in women receiving Gestranol].
    Giermańska T; Jablońska K; Filc-Bauer A
    Pol Tyg Lek; 1972 Nov; 27(48):1879-81. PubMed ID: 4118934
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with Ovosiston for inhibition of ovulation].
    Kühne D
    Dtsch Gesundheitsw; 1966 Feb; 21(8):377-9. PubMed ID: 4165201
    [No Abstract]   [Full Text] [Related]  

  • 17. Electroencephalographic changes during long term treatment with oral contraceptives.
    Matsumoto S; Sato I; Ito T; Matsuoka A
    Int J Fertil; 1966; 11(2):195-204. PubMed ID: 4163250
    [No Abstract]   [Full Text] [Related]  

  • 18. [1st clinical experiences on the use of oral contraceptive Ovosiston in diabetics].
    Gödel E; Gödel B
    Dtsch Gesundheitsw; 1970 Apr; 25(14):627-31. PubMed ID: 4098543
    [No Abstract]   [Full Text] [Related]  

  • 19. Cooperative studies of sequens, a sequential oral contraceptive agent, in Japan.
    Sawasaki C; Ashitaka Y
    J Jpn Obstet Gynecol Soc; 1968 Apr; 15(2):96-107. PubMed ID: 4175084
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone alterations by a sequential-type oral contraceptive.
    Spellacy WN; Buhi WC; Bendel RP
    Obstet Gynecol; 1969 Apr; 33(4):506-10. PubMed ID: 4180423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.